Efanesoctocog alfa is efficacious in treating severe hemophilia A
1. Efanesoctocog alfa was superior to prestudy factor VIII prophylaxis in preventing bleeding in patients with severe hemophilia A. 2. ...
1. Efanesoctocog alfa was superior to prestudy factor VIII prophylaxis in preventing bleeding in patients with severe hemophilia A. 2. ...
1. Risk of hospital admission was lower in the ferric derisomaltose group versus usual care. 2. Treatment-related adverse events were ...
1. In this population-based cohort study, apixaban was associated with a lower risk of gastrointestinal bleeding (GIB) as compared to ...
1. In comparison to rivaroxaban, apixaban was associated with a lower rate of bleeding events and embolic events amongst adults ...
1. Scoop thrombectomy is a safe and effective novel technique for treating thrombosed arteriovenous fistulas (AVFs) used for hemodialysis. Evidence ...
Post-intensive care syndrome in out-of-hospital cardiac arrest patients: A prospective observational cohort study 1. Approximately half of patients with out-of-hospital ...
1. Rivaroxaban was not associated with a lower rate of cardiovascular events and death compared to vitamin K antagonist treatment ...
Click here to read this study in JAMA.
1. 80% of patients receiving mitapivat showed hemoglobin response at 12 weeks. 2. Markers of hemolysis, such as bilirubin and ...
1. Hemophilia B patients treated with the adeno-associated virus (AAV) gene therapy produced dose-dependent sustained factor IX levels. 2. All ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.